Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ME

23andMe (ME)

23andMe Holding Company
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ME
DateTimeSourceHeadlineSymbolCompany
08/05/20245:43AMIH Market NewsNvidia AI Chip Delays, Mars Eyes Kellanova Acquisition, Berkshire Hathaway’s Cash Surge to $277 BillionNASDAQ:ME23andMe Holding Company
08/02/20248:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
08/02/20248:00AMGlobeNewswire Inc.23andMe Special Committee responds to CEO’s take-private proposalNASDAQ:ME23andMe Holding Company
08/01/20248:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
08/01/20248:00AMGlobeNewswire Inc.23andMe Announces CEO’s Take-Private ProposalNASDAQ:ME23andMe Holding Company
07/31/20245:01PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ME23andMe Holding Company
07/25/20244:45PMGlobeNewswire Inc.23andMe to Report Q1 FY2025 Financial ResultsNASDAQ:ME23andMe Holding Company
07/25/20247:30AMGlobeNewswire Inc.Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance ResearchNASDAQ:ME23andMe Holding Company
07/16/20244:54PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ME23andMe Holding Company
07/16/20244:53PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ME23andMe Holding Company
07/16/20244:52PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ME23andMe Holding Company
06/28/20247:00AMGlobeNewswire Inc.23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker PanelNASDAQ:ME23andMe Holding Company
06/10/20244:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
06/05/20247:00AMGlobeNewswire Inc.23andMe Launches New Genetic Report on Bipolar DisorderNASDAQ:ME23andMe Holding Company
06/04/20247:00AMGlobeNewswire Inc.23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black CommunityNASDAQ:ME23andMe Holding Company
06/03/20248:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
06/03/20248:00AMGlobeNewswire Inc.23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual MeetingNASDAQ:ME23andMe Holding Company
05/29/20248:00AMGlobeNewswire Inc.Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and historyNASDAQ:ME23andMe Holding Company
05/24/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
05/23/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
05/23/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
05/23/20244:05PMGlobeNewswire Inc.23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial ResultsNASDAQ:ME23andMe Holding Company
05/21/20244:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
05/21/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
05/14/20247:00AMGlobeNewswire Inc.Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsNASDAQ:ME23andMe Holding Company
05/10/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
05/09/20244:50PMGlobeNewswire Inc.23andMe to Report Q4 and Full Year FY2024 Financial ResultsNASDAQ:ME23andMe Holding Company
04/30/202411:00AMBusiness WirePotter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach CaseNASDAQ:ME23andMe Holding Company
04/24/20244:05PMGlobeNewswire Inc.23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:ME23andMe Holding Company
04/18/20248:00AMGlobeNewswire Inc.23andMe announces CEO’s intention to pursue a potential take-privateNASDAQ:ME23andMe Holding Company
 Showing the most relevant articles for your search:NASDAQ:ME

Your Recent History

Delayed Upgrade Clock